Seattle Angel Conference to win funding for your startup or learn how to angel invest logo

We are developing a low toxicity form of rapamycin, an mTOR inhibitor; mTOR activity is increased in cancer. To get eRapa approved efficiently, we have chosen the rare disease, Familial Adenomatous Polyposis (FAP) where 100's to 1000's of polyps form in the colon and rectum as early as the teen years. 100% of these patients will develop colorectal cancer. After approval, we will expand to all high risk colorectal patients, then to other cancers.

Seattle Angel Conference to win funding for your startup or learn how to angel invest logo
Seattle Angel Conference is a program to learn how to angel invest and for startup companies seeking funding. Seattle Angel Conference is a program of Mossy Ventures.
Sign up for our newsletter
Mossy Ventures angel investing group in Seattle, WA logo
Copyright © 2024 Mossy Ventures
Privacy PolicyWeb Design & SEO by Symphysis
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram